Skip to content

Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, study finds

  • by
  • blog
  • 1 min read

A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low rates of severe disease, hospitalization, ICU admission and mortality, according to researchers.

Advertisements
Advertisements
Advertisements

Join the conversation

Your email address will not be published. Required fields are marked *

Related Posts

Syria longs for international aid amid earthquake devastation

The flow of critical UN aid to northwest Syria has been halted, as politics hampers assistance to government-held areas.

Loss of reptiles poses threat for small islands where humans may have caused extinctions

A new examination of ancient and current species of reptiles conducted by paleobiologists reveals the serious impact of the disappearance of even a few species… Read More »Loss of reptiles poses threat for small islands where humans may have caused extinctions

Long-term restoration of a biodiversity hotspot hinges on getting seeds to the right place at the right time

New research shows that degraded savanna ecosystems can reap lasting benefits from a single seeding of native understory plants. Once a diverse understory of savanna… Read More »Long-term restoration of a biodiversity hotspot hinges on getting seeds to the right place at the right time